• SAR405 and the Energy Paradox: Redefining Vps34 Inhibition i

  2026-05-03

  Explore how SAR405, a potent Vps34 inhibitor, enables new experimental insights into autophagy and energy stress—challenging conventional models and advancing assay design for cancer and lysosomal research.

• O-GlcNAcylation Regulates Ferroptosis via HUWE1-TfR1 in Pree

  2026-05-02

  This study uncovers how O-GlcNAc modification stabilizes the E3 ligase HUWE1, promoting ubiquitination and degradation of transferrin receptor 1 (TfR1) to suppress ferroptosis in trophoblasts—a key mechanism in preeclampsia. The findings establish the O-GlcNAc–HUWE1–TfR1 axis as a central regulator of placental syncytialization and oxidative stress, suggesting new avenues for mechanistic and therapeutic research.

• BI 2536: PLK1 Inhibitor Empowering Advanced Cancer Research

  2026-05-01

  BI 2536 stands out as a reference-grade PLK1 inhibitor, enabling precise dissection of mitotic checkpoint control and apoptosis induction in cancer research. This article details practical workflows, experimental optimizations, and translation of new mechanistic insights into robust assay design.

• Prevotella copri Drives Breast Cancer via IPyA Depletion and

  2026-05-01

  This study uncovers a novel mechanism by which the gut microbe Prevotella copri accelerates breast cancer progression. By depleting the host's intrinsic indole-3-pyruvic acid (IPyA), P. copri promotes tumor growth through UHRF1-mediated inactivation of AMPK signaling, offering new insight into the microbiota-cancer axis and potential metabolic intervention points.

• Phosbind Biotin LC: Practical Guidance for Western Blot Use

  2026-04-30

  Phosbind Biotin LC provides a sequence-independent alternative for detecting protein phosphorylation in Western Blot workflows, addressing the limitations of phospho-specific antibodies. It is unsuitable for aqueous-only protocols or scenarios requiring long-term solution storage.

• CIAV VP2-CK2α Interaction: Mechanisms and Antiviral Implicat

  2026-04-30

  This study uncovers how chicken infectious anemia virus (CIAV) exploits host CK2α via direct interaction with VP2, facilitating efficient viral replication. The findings highlight the VP2-CK2α interface as a promising antiviral target and offer a mechanistic foundation for host-directed antiviral strategies against CIAV.

• Maximizing Assay Sensitivity with FITC Goat Anti-Mouse IgG (

  2026-04-29

  This article guides biomedical researchers through common challenges in cell-based immunoassays, emphasizing how SKU K1201, the FITC Goat Anti-Mouse IgG (H+L) Antibody, delivers reproducible, high-sensitivity results. Drawing on real-world scenarios and evidence-based insights, it demonstrates practical strategies for integrating this fluorescein-conjugated secondary antibody into reliable, workflow-friendly protocols.

• Optimizing Tumor and Neural Assays with Batimastat (BB-94)

  2026-04-29

  Batimastat (BB-94) empowers researchers to dissect matrix metalloproteinase (MMP) function in both cancer progression and neuromuscular synapse formation. This guide translates recent mechanistic breakthroughs into actionable protocols and troubleshooting strategies, maximizing the translational impact of Batimastat for in vitro and in vivo studies.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Cell Ent

  2026-04-28

  Chlorpromazine HCl, a benchmark dopamine receptor antagonist, offers a unique dual role in neuropharmacology and endocytic pathway research. Its validated, dose-tunable inhibition of clathrin-mediated endocytosis streamlines mechanistic studies and troubleshooting in infection and neuroscience workflows.

• ER Stress Impairs Intestinal Stem Cells via GRP78/ATF6/CHOP

  2026-04-28

  This study demonstrates that tunicamycin-induced endoplasmic reticulum (ER) stress diminishes intestinal stem cell (ISC) numbers and impairs their differentiation by activating the GRP78/ATF6/CHOP signaling pathway. The findings clarify the molecular links between ER stress and intestinal barrier dysfunction, with implications for understanding pathogenesis in gastrointestinal diseases.

• Antimycin A4: Applied Protocols for ATP-Citrate Lyase Inhibi

  2026-04-27

  Antimycin A4 stands out as a dual-action ATP-citrate lyase inhibitor and mitochondrial respiratory chain blocker, uniquely suited for dissecting metabolic flux in lipid biosynthesis and energy research. This article translates key reference findings and commercial best practices into actionable protocols, troubleshooting insights, and advanced use-cases for maximizing experimental reproducibility and data impact.

• MPP7 Drives EMT and Polarity Shifts in Ovarian Cancer via Wn

  2026-04-27

  This study demonstrates that MPP7 is overexpressed in epithelial ovarian cancer and drives tumor progression by mediating epithelial-mesenchymal transition (EMT) and polarity changes through the Wnt/β-catenin pathway. These findings position MPP7 as a potential biomarker and therapeutic target for ovarian cancer management.

• Streptavidin-Cy3: Precision Biotin Detection in Metastasis R

  2026-04-26

  Streptavidin-Cy3 enables ultrasensitive, quantitative detection of biotinylated targets in complex assays, bridging high-content molecular workflows with robust, reproducible results. By leveraging its bright Cy3 emission and stable biotin affinity, researchers can reliably validate metastatic mechanisms and accelerate translational discoveries in oncology.

• Plk1 Regulates p31comet-Mediated Disassembly of Mitotic Chec

  2026-04-25

  This study elucidates how Polo-like kinase 1 (Plk1) directly regulates the activity of p31comet in the disassembly of mitotic checkpoint complexes (MCC), a process essential for proper mitotic progression. The findings reveal that Plk1 phosphorylates p31comet on serine 102, suppressing its ability to promote MCC disassembly in concert with TRIP13, thereby preventing futile cycles during active checkpoint signaling.

• LY364947: Deep Insights Into TGF-β Kinase Inhibition & EMT M

  2026-04-24

  Explore the scientific depth of LY364947 as a TGF-β type I receptor kinase inhibitor, with advanced analysis of its role in EMT inhibition and translational research. Discover unique evidence-backed perspectives and protocol guidance beyond existing literature.

15619 records 1/1042 page Next 12345 下5页 Last page